Myhealthywaist.org News Feed

High-density lipoprotein cholesterol as the Holy Grail. JAMA 2011;306:2153-5

Fri, 03 Feb 2012 00:00:00 -0500

Cannon CP.

Cardiology in 2011--amazing opportunities, huge challenges. JAMA 2011;306:2158-9

Fri, 03 Feb 2012 00:00:00 -0500

Peterson ED, Gaziano JM.

Statin therapy in primary CVD prevention remains a hot-button topic for some. JAMA 2011;306:2077-8

Fri, 03 Feb 2012 00:00:00 -0500

Mitka M.

Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA 2011;306:2137-44

Thu, 02 Feb 2012 00:00:00 -0500

Ovbiagele B, Diener HC, Yusuf S, Martin RH, Cotton D, Vinisko R, Donnan GA, Bath PM; PROFESS Investigators.

Prevention of cardiovascular disease and stroke: meeting the challenge. JAMA 2011;306:2147-8

Thu, 02 Feb 2012 00:00:00 -0500

Tomaselli GF.

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial. JAMA 2011;306:2099-109

Thu, 02 Feb 2012 00:00:00 -0500

Nicholls SJ, Brewer HB, Kastelein JJ, Krueger KA, Wang MD, Shao M, Hu B, McErlean E, Nissen SE.

Abdominal and gynoid adiposity and the risk of stroke. Int J Obes (Lond) 2011;35:1427-32

Wed, 01 Feb 2012 00:00:00 -0500

Toss F, Wiklund P, Franks PW, Eriksson M, Gustafson Y, Hallmans G, Nordstr�m P, Nordstr�m A.

Body composition and body fat distribution in relation to later risk of acute myocardial infarction: a Danish follow-up study. Int J Obes (Lond) 2011;35:1433-41

Wed, 01 Feb 2012 00:00:00 -0500

Stegger JG, Schmidt EB, Obel T, Berentzen TL, Tj�nneland A, S�rensen TI, Overvad K.

Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA 2011;306:2120-7

Wed, 01 Feb 2012 00:00:00 -0500

Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, Gibson CM, Pollack CV Jr, Ornato JP, Zalenski RJ, Penney J, Tiefenbrunn AJ, Greenland P; NRMI Investigators.

Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss. Int J Obes (Lond) 2011;35:1377-84

Tue, 31 Jan 2012 00:00:00 -0500

Bennetzen MF, Wellner N, Ahmed SS, Ahmed SM, Diep TA, Hansen HS, Richelsen B, Pedersen SB.

The impact of obesity on physiological responses during prolonged exercise. Int J Obes (Lond) 2011;35:1404-12

Tue, 31 Jan 2012 00:00:00 -0500

Eijsvogels TM, Veltmeijer MT, Schreuder TH, Poelkens F, Thijssen DH, Hopman MT.

Impact of weight change, secular trends and ageing on cardiovascular risk factors: 10-year experiences from the SOS study. Int J Obes (Lond) 2011;35:1413-20

Tue, 31 Jan 2012 00:00:00 -0500

Sj�str�m CD, Lystig T, Lindroos AK.

Intensive practical lifestyle intervention improves endothelial function in metabolic syndrome independent of weight loss: a randomized controlled trial. Metabolism 2011;60:1736-40

Mon, 30 Jan 2012 00:00:00 -0500

Seligman BG, Polanczyk CA, Santos AS, Foppa M, Junges M, Bonzanini L, Nicolaidis G, Camey S, Lopes AL, Sehl P, Duncan BB, Clausell N.

Lifestyle factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med 2011;171:1811-8

Mon, 30 Jan 2012 00:00:00 -0500

Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G.

Predictors of blood pressure control among hypertensives in community health centers. Am J Hypertens 2011;24:1318-23

Mon, 30 Jan 2012 00:00:00 -0500

Shelley D, Tseng TY, Andrews H, Ravenell J, Wu D, Ferrari P, Cohen A, Millery M, Kopal H.

Effects of acute ingestion of different fats on oxidative stress and inflammation in overweight and obese adults. Nutr J 2011;10:122

Fri, 27 Jan 2012 00:00:00 -0500

Peairs AD, Rankin JW, Lee YW.

Effects of leptin and adiponectin on pancreatic β-cell function. Metabolism 2011;60:1664-72

Fri, 27 Jan 2012 00:00:00 -0500

Lee YH, Magkos F, Mantzoros CS, Kang ES.

Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides � glucose versus triglyceride/high-density lipoprotein cholesterol. Metabolism 2011;60:1673-6

Fri, 27 Jan 2012 00:00:00 -0500

Abbasi F, Reaven GM.

Threshold for the upper normal limit of indexed epicardial fat volume: derivation in a healthy population and validation in an outcome-based study. Am J Cardiol 2011;108:1680-5

Thu, 26 Jan 2012 00:00:00 -0500

Shmilovich H, Dey D, Cheng VY, Rajani R, Nakazato R, Otaki Y, Nakanishi R, Slomka PJ, Thomson LE, Hayes SW, Friedman JD, Gransar H, Wong ND, Shaw LJ, Budoff M, Rozanski A, Berman DS.

Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure. J Lipid Res 2011;52:2169-76

Thu, 26 Jan 2012 00:00:00 -0500

Cao G, Beyer TP, Zhang Y, Schmidt RJ, Chen YQ, Cockerham SL, Zimmerman KM, Karathanasis SK, Cannady EA, Fields T, Mantlo NB.